200 related articles for article (PubMed ID: 26048978)
1. The generation of macrophages with anti-inflammatory activity in the absence of STAT6 signaling.
Fleming BD; Chandrasekaran P; Dillon LA; Dalby E; Suresh R; Sarkar A; El-Sayed NM; Mosser DM
J Leukoc Biol; 2015 Sep; 98(3):395-407. PubMed ID: 26048978
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter.
Liddiard K; Welch JS; Lozach J; Heinz S; Glass CK; Greaves DR
BMC Mol Biol; 2006 Nov; 7():45. PubMed ID: 17134490
[TBL] [Abstract][Full Text] [Related]
3. Pyropia yezoensis glycoprotein promotes the M1 to M2 macrophage phenotypic switch via the STAT3 and STAT6 transcription factors.
Choi JW; Kwon MJ; Kim IH; Kim YM; Lee MK; Nam TJ
Int J Mol Med; 2016 Aug; 38(2):666-74. PubMed ID: 27353313
[TBL] [Abstract][Full Text] [Related]
4. Src promotes anti-inflammatory (M2) macrophage generation via the IL-4/STAT6 pathway.
Hu X; Wang H; Han C; Cao X
Cytokine; 2018 Nov; 111():209-215. PubMed ID: 30176559
[TBL] [Abstract][Full Text] [Related]
5. LncGBP9/miR-34a axis drives macrophages toward a phenotype conducive for spinal cord injury repair via STAT1/STAT6 and SOCS3.
Zhou J; Li Z; Wu T; Zhao Q; Zhao Q; Cao Y
J Neuroinflammation; 2020 Apr; 17(1):134. PubMed ID: 32345320
[TBL] [Abstract][Full Text] [Related]
6. The Transcription Factor STAT6 Mediates Direct Repression of Inflammatory Enhancers and Limits Activation of Alternatively Polarized Macrophages.
Czimmerer Z; Daniel B; Horvath A; Rückerl D; Nagy G; Kiss M; Peloquin M; Budai MM; Cuaranta-Monroy I; Simandi Z; Steiner L; Nagy B; Poliska S; Banko C; Bacso Z; Schulman IG; Sauer S; Deleuze JF; Allen JE; Benko S; Nagy L
Immunity; 2018 Jan; 48(1):75-90.e6. PubMed ID: 29343442
[TBL] [Abstract][Full Text] [Related]
7. The IL-4/STAT6 signaling axis establishes a conserved microRNA signature in human and mouse macrophages regulating cell survival via miR-342-3p.
Czimmerer Z; Varga T; Kiss M; Vázquez CO; Doan-Xuan QM; Rückerl D; Tattikota SG; Yan X; Nagy ZS; Daniel B; Poliska S; Horvath A; Nagy G; Varallyay E; Poy MN; Allen JE; Bacso Z; Abreu-Goodger C; Nagy L
Genome Med; 2016 May; 8(1):63. PubMed ID: 27245778
[TBL] [Abstract][Full Text] [Related]
8. The pro-inflammatory cytokine, interleukin-6, enhances the polarization of alternatively activated macrophages.
Fernando MR; Reyes JL; Iannuzzi J; Leung G; McKay DM
PLoS One; 2014; 9(4):e94188. PubMed ID: 24736635
[TBL] [Abstract][Full Text] [Related]
9. Th2 Cytokines Augment IL-31/IL-31RA Interactions via STAT6-dependent IL-31RA Expression.
Edukulla R; Singh B; Jegga AG; Sontake V; Dillon SR; Madala SK
J Biol Chem; 2015 May; 290(21):13510-20. PubMed ID: 25847241
[TBL] [Abstract][Full Text] [Related]
10. IL-4 blocks M-CSF-dependent macrophage proliferation by inducing p21Waf1 in a STAT6-dependent way.
Arpa L; Valledor AF; Lloberas J; Celada A
Eur J Immunol; 2009 Feb; 39(2):514-26. PubMed ID: 19130475
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine 1-phosphate induced anti-atherogenic and atheroprotective M2 macrophage polarization through IL-4.
Park SJ; Lee KP; Kang S; Lee J; Sato K; Chung HY; Okajima F; Im DS
Cell Signal; 2014 Oct; 26(10):2249-58. PubMed ID: 25035231
[TBL] [Abstract][Full Text] [Related]
12. The neuron-derived orphan receptor 1 (NOR1) is induced upon human alternative macrophage polarization and stimulates the expression of markers of the M2 phenotype.
De Paoli F; Eeckhoute J; Copin C; Vanhoutte J; Duhem C; Derudas B; Dubois-Chevalier J; Colin S; Zawadzki C; Jude B; Haulon S; Lefebvre P; Staels B; Chinetti-Gbaguidi G
Atherosclerosis; 2015 Jul; 241(1):18-26. PubMed ID: 25941992
[TBL] [Abstract][Full Text] [Related]
13. Pro-inflammatory cytokines negatively regulate PPARγ mediated gene expression in both human and murine macrophages via multiple mechanisms.
Nagy ZS; Czimmerer Z; Szanto A; Nagy L
Immunobiology; 2013 Nov; 218(11):1336-44. PubMed ID: 23870825
[TBL] [Abstract][Full Text] [Related]
14. Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology.
Pello OM; De Pizzol M; Mirolo M; Soucek L; Zammataro L; Amabile A; Doni A; Nebuloni M; Swigart LB; Evan GI; Mantovani A; Locati M
Blood; 2012 Jan; 119(2):411-21. PubMed ID: 22067385
[TBL] [Abstract][Full Text] [Related]
15. Dissociation of endotoxin tolerance and differentiation of alternatively activated macrophages.
Rajaiah R; Perkins DJ; Polumuri SK; Zhao A; Keegan AD; Vogel SN
J Immunol; 2013 May; 190(9):4763-72. PubMed ID: 23543762
[TBL] [Abstract][Full Text] [Related]
16. C16, a novel sinomenine derivatives, promoted macrophage reprogramming toward M2-like phenotype and protected mice from endotoxemia.
Ni P; Liu YQ; Man JY; Li W; Xue SS; Lu TH; Su ZL; Zhou CL
Int J Immunopathol Pharmacol; 2021; 35():20587384211026786. PubMed ID: 34190613
[TBL] [Abstract][Full Text] [Related]
17. Extensive and functional overlap of the STAT6 and RXR cistromes in the active enhancer repertoire of human CD14+ monocyte derived differentiating macrophages.
Czimmerer Z; Nagy ZS; Nagy G; Horvath A; Silye-Cseh T; Kriston A; Jonas D; Sauer S; Steiner L; Daniel B; Deleuze JF; Nagy L
Mol Cell Endocrinol; 2018 Aug; 471():63-74. PubMed ID: 28774779
[TBL] [Abstract][Full Text] [Related]
18. Macrophage alternative activation confers protection against lipotoxicity-induced cell death.
Dai L; Bhargava P; Stanya KJ; Alexander RK; Liou YH; Jacobi D; Knudsen NH; Hyde A; Gangl MR; Liu S; Lee CH
Mol Metab; 2017 Oct; 6(10):1186-1197. PubMed ID: 29031719
[TBL] [Abstract][Full Text] [Related]
19. Antiinflammatory properties of a peptide derived from interleukin-4.
Klementiev B; Enevoldsen MN; Li S; Carlsson R; Liu Y; Issazadeh-Navikas S; Bock E; Berezin V
Cytokine; 2013 Oct; 64(1):112-21. PubMed ID: 23972727
[TBL] [Abstract][Full Text] [Related]
20. Luteolin Alters Macrophage Polarization to Inhibit Inflammation.
Wang S; Cao M; Xu S; Shi J; Mao X; Yao X; Liu C
Inflammation; 2020 Feb; 43(1):95-108. PubMed ID: 31673976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
